Arthritis, Musculoskeletal and Skin Diseases Research in Minnesota
Arthritis, Musculoskeletal and Skin Diseases Research (93.846) awarded $80.1 million to recipients in Minnesota in 89 grants from fiscal 2021 to 2025, 3.0% of the program's national total. Regents of the University of Minnesota received the most, $39.3 million.
- Awarded in Minnesota$80.1 million
- Awards89
- Share of the program3.0%
- Rank among states11th of 44
- National total$2.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 38 | $16.6 million |
| FY 2022 | 40 | $15.8 million |
| FY 2023 | 47 | $15.3 million |
| FY 2024 | 43 | $16.6 million |
| FY 2025 | 37 | $15.8 million |
Recipients in Minnesota
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Regents of the University of Minnesota | Colleges and universities | 40 | $39.3 million |
| Mayo Clinic | Nonprofits | 38 | $35.0 million |
| Innovative Design Labs Inc | Small businesses | 1 | $2.0 million |
| Myogenica Inc. | Small businesses | 1 | $1.3 million |
| Emmyon, Inc. | Small businesses | 1 | $745,404 |
| Healthpartners Institute | Nonprofits | 1 | $556,160 |
| Agitated Solutions Inc. | Small businesses | 1 | $281,978 |
| Kommodo Therapeutics LLC | Small businesses | 1 | $281,514 |
| Ascan L. L. C | Small businesses | 1 | $276,073 |
| Recombinetics Inc | Small businesses | 1 | $228,863 |
Open opportunities under this program
- Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
- Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
- HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed)
- NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
See all 62 on the program page
Questions people ask
How much Arthritis, Musculoskeletal and Skin Diseases Research money goes to Minnesota?
$80.1 million from fiscal 2021 to 2025, across 89 awards. Minnesota ranks 11th of 44 states and territories for this program.
Who receives Arthritis, Musculoskeletal and Skin Diseases Research money in Minnesota?
The largest recipient is Regents of the University of Minnesota, with $39.3 million in 40 awards. Next are Mayo Clinic and Innovative Design Labs Inc.
Can organizations in Minnesota apply now?
Yes, 62 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Arthritis, Musculoskeletal and Skin Diseases Research in other states
Other large programs in Minnesota
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Temporary Assistance for Needy Families
- Federal Transit Capital Investment Grants
- Special Education Grants to States
- Child Care and Development Block Grant
- Federal Transit Formula Grants
- Affordable Rural Cooperative